Development and clinical application of perfluorochemical artificial blood.
A review of the authors' experience on the use of Fluosol DA. This includes studies on animals and also clinical trials on patients.
D000208:Acute Disease; D000818:Animals; D001692:Biological Transport; D001784:Blood Gas Analysis; D001802:Blood Substitutes; D004338:Drug Combinations / Q000378:metabolism / Q000627:therapeutic use; D004655:Emulsions; D005466:Fluorocarbons / Q000378:metabolism / Q000627:therapeutic use; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D008253:Macaca mulatta; D010100:Oxygen / Q000378:metabolism; D010316:Particle Size; D012771:Shock, Hemorrhagic / Q000628:therapy
D001802:Blood Substitutes; D004338:Drug Combinations; D004655:Emulsions; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D010100:Oxygen